Article Text

other Versions

PDF
Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer’s disease
  1. Kiri L Brickell (allan.kiri{at}xtra.co.nz)
  1. Neurological Foundation of New Zealand, New Zealand
    1. James B Leverenz
    1. University of Washington and VA Puget Sound Health Care System, United States
      1. Ellen J Steinbart
      1. University of Washington and VA Puget Sound Health Care System, United States
        1. Malia Rumbaugh
        1. VA Puget Sound Health Care System, United States
          1. Gerard D Schellenberg
          1. University of Washington and VA Puget Sound Health Care System, United States
            1. David Nochlin
            1. JFK Medical Center, United States
              1. Thomas H Lampe
              1. VA Puget Sound Health Care System, United States
                1. Ida E Holm
                1. Aarhus University Hospital, Denmark
                  1. Vivianna Van Deerlin
                  1. University of Pennsylvania Health System, United States
                    1. Wuxing Yuan
                    1. University of Pennsylvania Health System, United States
                      1. Thomas D Bird (tomnroz{at}u.washington.edu)
                      1. University of Washington and VA Puget Sound Health Care System, United States

                        Abstract

                        Aim: Neuropathologic examination of both individuals in a monozyotic (MZ) twin pair with Alzheimer’s disease (AD) is rare especially in the molecular genetic era. We had the opportunity to assess the concordance and discordance of clinical presentation and neuropathology in 3 monozygotic twin pairs with Alzheimer’s disease (AD).

                        Methods: The MZ twins were identified and characterized by the University of Washington Alzheimer’s Disease Research Center (UW ADRC). We reviewed the available clinical and neuropathological records for all 6 cases looking specifically for concordance and discordance of clinical phenotype, neuritic amyloid plaques (NP), neurofibrillary tangles (NFT) and Lewy related pathology (LRP).

                        Results: Discordance in age of onset for developing AD in the MZ twins varied from 4-18 years. Clinical presentations also differed between twins. One twin presented with a Dementia with Lewy Body (DLB) clinical syndrome while the other presented with typical clinical AD. Neuropathology within the MZ twin pairs was concordant for NP and NFT regardless of duration of disease and was discordant for LRP. This difference was most marked in the late onset AD twin pair. One pair was found to have a mutation in presenilin-1 (PS1) (A79V) with remarkably late onset in a family member.

                        Conclusions: MZ twins with AD can vary considerably in age of onset, presentation and disease duration. The concordance of NP and NFT pathologic change and the discordance of LRP support the concept that, in AD, the former are primarily under genetic control whereas the latter (LRP) is more influenced by disease duration and environmental factors. The A79V mutation in PS1 can be associated with very late onset of dementia.

                        • alzheimer's disease
                        • monozygotic twins
                        • neuropathology
                        • presenilin 1

                        Statistics from Altmetric.com

                        Request permissions

                        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                        Linked Articles